Sina Kohlbrenner, Author at BaseLaunch

Alentis starts first in-human clinical trial

Alentis Therapeutics starts their first-in-human clinical trial

FDA greenlights Alentis Phase 1 protocol study design Alentis to begin transition from pre-clinical to clinical Basel, Switzerland., 04 January 2022 — Alentis Therapeutics, AG…

Sina Kohlbrenner06.01.2022

Anaveon_-startups_Switzerland-credit-Jasmin-Rei

All Portfolio news

Anaveon raises 110 Million Swiss francs in Series B financing

Back in 2017, when we first met Andreas Katopodis, he had the vision to build a company that translates breakthrough science in the field of…

Sina Kohlbrenner17.12.2021

All Interviews Team interviews

Featured Interview: Stephan Emmerth, Director Business Development & Operations, BaseLaunch

Swiss biotech venture accelerator and incubator BaseLaunch was started in 2017 to help launch and grow the next generation of biotech companies. The accelerator has…

Sina Kohlbrenner16.12.2021

All Company interviews Interviews

“We master all the tricks of the trade” Interview with Thomas Fessard CEO of SpiroChem

Founded in 2011, the company moved to Basel in 2017. Today, SpiroChem has gained an excellent reputation for delivering best-in-class chemistry services and works with…

Sina Kohlbrenner01.11.2021

All Features

Building a biotechnology ecosystem

Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. The company provides affordable and non-exclusive access to…

Sina Kohlbrenner01.11.2021

All Features

Premier news: KPMG renews its commitment

We are delighted to announce that KPMG, is continuing its partnership with BaseLaunch to help support cutting-edge early-stage biotechs to achieve financing and grow their…

Sina Kohlbrenner01.11.2021

All Features

Several of our companies are looking for experienced biopharma talent

"People Wanted: For hazardous journey. Small wages, bitter cold, long months of complete darkness, constant danger, safe return doubtful. Honor and recognition in case of…

Sina Kohlbrenner01.11.2021

All Portfolio news

Engimmune Therapeutics joins BaseLaunch Portfolio

Engimmune Therapeutics is a platform and product development company using cutting-edge technologies in the life sciences to engineer highly potent and specific therapies based on…

Sina Kohlbrenner26.10.2021